Trial · NCT00300430
Adverse events471
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 471
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhea | Gastrointestinal disorders | ABT-335 + 20 mg Rosuvastatin | 49 | 1,186 | |
| other | Diarrhea | Gastrointestinal disorders | ABT-335 + 40 mg Simvastatin | 26 | 514 | |
| other | Diarrhea | Gastrointestinal disorders | ABT-335 + 40 mg Atorvastatin | 33 | 501 | |
| other | Dyspepsia | Gastrointestinal disorders | ABT-335 + 20 mg Rosuvastatin | 42 | 1,186 | |
| other | Dyspepsia | Gastrointestinal disorders | ABT-335 + 40 mg Simvastatin | 31 | 514 | |
| other | Dyspepsia | Gastrointestinal disorders | ABT-335 + 40 mg Atorvastatin | 28 | 501 | |
| other | Nausea | Gastrointestinal disorders | ABT-335 + 20 mg Rosuvastatin | 61 | 1,186 | |
| other | Nausea | Gastrointestinal disorders | ABT-335 + 40 mg Simvastatin | 23 | 514 | |
| other | Nausea | Gastrointestinal disorders | ABT-335 + 40 mg Atorvastatin | 34 | 501 | |
| other | Bronchitis | Infections and infestations | ABT-335 + 20 mg Rosuvastatin | 60 | 1,186 | |
| other | Bronchitis | Infections and infestations | ABT-335 + 40 mg Simvastatin | 25 | 514 | |
| other | Bronchitis | Infections and infestations | ABT-335 + 40 mg Atorvastatin | 23 | 501 | |
| other | Nasopharyngitis | Infections and infestations | ABT-335 + 20 mg Rosuvastatin | 116 | 1,186 | |
| other | Nasopharyngitis | Infections and infestations | ABT-335 + 40 mg Simvastatin | 70 | 514 | |
| other | Nasopharyngitis | Infections and infestations | ABT-335 + 40 mg Atorvastatin | 58 | 501 | |
| other | Sinusitis | Infections and infestations | ABT-335 + 20 mg Rosuvastatin | 91 | 1,186 | |
| other | Sinusitis | Infections and infestations | ABT-335 + 40 mg Simvastatin | 40 | 514 | |
| other | Sinusitis | Infections and infestations | ABT-335 + 40 mg Atorvastatin | 37 | 501 | |
| other | Upper respiratory tract infection | Infections and infestations | ABT-335 + 20 mg Rosuvastatin | 145 | 1,186 | |
| other | Upper respiratory tract infection | Infections and infestations | ABT-335 + 40 mg Simvastatin | 69 | 514 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00300430/events